Clinical Evaluation of an In-House Reverse Transcription-Competitive PCR for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Microbiology

• Publication date

  1999-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JCM.37.2.333-338.1999PMID 9889213PMCID PMC84299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE

  2000cited by this paper
• Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

  1997cited by this paper
• Development of a reverse transcriptase PCR-enzyme-linked immunosorbent assay for quantification of human immunodeficiency virus type 1 RNA in plasma: comparison with commercial quantitative assays

  1997cited by this paper
• Quantitative RT-PCR for human Fas (CD95) expression.

  1997cited by this paper
• Change in circulating levels of the chemokines macrophage inflammatory proteins 1α and 1β, RANTES, monocyte chemotactic protein‐1 and interleukin‐16 following treatment of severely immunodeficient HIV‐infected individuals with indinavir

  1997influential reference
• A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity

  1997cited by this paper
• Improved methods for quantification of human immunodeficiency virus type 1 RNA and hepatitis C virus RNA in blood using spin column technology and chemiluminescent assays of PCR products

  1997cited by this paper
• Detection of low HIV-1 RNA levels in plasma.

  1997cited by this paper
• Comparison of QIAamp HCV kit spin columns, silica beads, and phenol-chloroform for recovering human immunodeficiency virus type 1 RNA from plasma

  1997cited by this paper
• A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml.

  1997cited by this paper
• Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects

  1996cited by this paper
• Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

  1996cited by this paper
• Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma

  1996influential reference
• Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma

  1996cited by this paper
• The Effect of High-Dose Saquinavir on Viral Load and CD4+ T-Cell Counts in HIV-Infected Patients

  1996cited by this paper
• Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: Longitudinal evaluation of six patients under treatment

  1996cited by this paper
• An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma

  1996cited by this paper
• Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma

  1996influential reference
• Advances in antiretroviral therapy and viral load monitoring.

  1996cited by this paper
• The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.

  1996cited by this paper
• Quantitation of human immunodeficiency virus type 1 DNA by two PCR procedures coupled with enzyme-linked oligosorbent assay

  1995cited by this paper
• Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort

  1995cited by this paper
• A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group.

  1995cited by this paper
• Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay

  1995cited by this paper
• Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds

  1995influential reference
• Quantitative PCR and RT-PCR in virology.

  1993cited by this paper
• Development and validation of a polymerase chain reaction method for the precise quantitation of HIV‐1 DNA in blood cells from subjects undergoing a 1‐year immunotherapeutic treatment

  1993cited by this paper
• Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species.

  1993cited by this paper
• Rapid cycle DNA amplification: time and temperature optimization.

  1991cited by this paper

• Sequencing of One Unique Recombinant CRF85_BC/CRF01_AE Genome and Two Partial Genomes from Ningxia, China

  2025cites this paper
• Use of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections

  2010cites this paper
• Efficient methodologies for sensitive HIV-1 RNA quantitation from plasma and vaginal secretions.

  2009cites this paper
• Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients.

  2004cites this paper
• Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV‐1‐infected subjects

  2002cites this paper
• Development and significance of resistance to protease inhibitors in HIV‐1‐infected adults under triple‐drug therapy in clinical practice

  2002cites this paper
• Diagnosis of HIV infection and laboratory monitoring of its therapy.

  2001cites this paper
• Ultrasensitive in-house reverse transcription-competitive PCR for quantitation of HIV-1 RNA in plasma.

  2000cites this paper
• Analysis of the HIV‐1 nef gene in five intravenous drug users with long‐term nonprogressive HIV‐1 infection in Italy

  2000cites this paper
• Genotypic Resistance to Zidovudine as a Predictor of Failure of Subsequent Therapy with Human Immunodeficiency Virus Type-1 Nucleoside Reverse-Transcriptase Inhibitors

  1999cites this paper
• Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine, and protease inhibitors.

  1999cites this paper
• A novel, internally competitive polymerase chain reaction for quantification of human cytomegalovirus DNA in human leukocytes.

  1999cites this paper